Decision makers need an approach to determine digital therapeutic product quality, access, and appropriate use.
Where this comes from
- Record sourced from PubMed, PMID 33769855.
- Also identified by DOI 10.18553/jmcp.2021.27.4.536 and PMC identifier 10391241.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<b>DISCLOSURES:</b> No funding was received for the writing of this article. Parcher is employed by Xcenda and has nothing to disclose. Coder is employed by Digital Therapeutics Alliance, which is a member of the USP Convention. Coder reports fees from PsychU/Otsuka.
Medical subject headings
- Digital Technology
- Pharmaceutical Services
- Telemedicine